Immatics NV (IMTX)
7.31
-0.23
(-3.05%)
USD |
NASDAQ |
Oct 23, 16:00
7.315
0.00 (0.00%)
After-Hours: 20:00
Immatics Enterprise Value : 566.19M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 566.19M |
| October 22, 2026 | 597.62M |
| October 21, 2026 | 618.13M |
| October 20, 2026 | 593.52M |
| October 19, 2026 | 530.65M |
| October 16, 2026 | 486.91M |
| October 15, 2026 | 542.95M |
| October 14, 2026 | 523.81M |
| October 13, 2026 | 500.57M |
| October 12, 2026 | 552.52M |
| October 09, 2026 | 582.59M |
| October 08, 2026 | 574.39M |
| October 07, 2026 | 585.32M |
| October 06, 2026 | 592.16M |
| October 05, 2026 | 623.60M |
| October 02, 2026 | 604.46M |
| October 01, 2026 | 720.65M |
| September 30, 2026 | 767.12M |
| September 29, 2026 | 737.05M |
| September 28, 2026 | 728.85M |
| September 25, 2026 | 711.08M |
| September 24, 2026 | 705.61M |
| September 23, 2026 | 742.52M |
| September 22, 2026 | 779.42M |
| September 21, 2026 | 758.92M |
| Date | Value |
|---|---|
| September 18, 2026 | 745.25M |
| September 17, 2026 | 772.59M |
| September 16, 2026 | 747.98M |
| September 15, 2026 | 742.52M |
| September 14, 2026 | 745.25M |
| September 11, 2026 | 768.49M |
| September 10, 2026 | 763.02M |
| September 09, 2026 | 812.23M |
| September 08, 2026 | 857.34M |
| September 04, 2026 | 873.74M |
| September 03, 2026 | 860.07M |
| September 02, 2026 | 865.54M |
| September 01, 2026 | 855.97M |
| August 31, 2026 | 869.64M |
| August 28, 2026 | 858.70M |
| August 27, 2026 | 846.40M |
| August 26, 2026 | 855.97M |
| August 25, 2026 | 830.00M |
| August 24, 2026 | 754.82M |
| August 21, 2026 | 787.62M |
| August 20, 2026 | 735.68M |
| August 19, 2026 | 831.36M |
| August 18, 2026 | 809.49M |
| August 17, 2026 | 831.36M |
| August 14, 2026 | 857.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| BioNTech SE | 5.602B |
| MediGene AG | -- |
| InflaRx NV | 49.62M |
| Twist Bioscience Corp. | 8.696B |
| Prime Medicine, Inc. | 680.71M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -72.66M |
| Revenue (Quarterly) | 10.63M |
| Total Expenses (Quarterly) | 83.29M |
| EPS Diluted (Quarterly) | -0.5316 |
| Profit Margin (Quarterly) | -683.4% |
| Earnings Yield | -25.30% |
| Normalized Earnings Yield | -25.31 |